The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of September 2023. This month there is one clinical guideline and one technology appraisal that impact upon primary care.
The Cirrhosis in over 16s: assessment and management guideline has been updated. It covers assessing and managing suspected or confirmed cirrhosis in people who are 16 years or older. The update adds new or updated recommendations on safe prescribing and use of carvedilol and propranolol in people with cirrhosis, preventing bleeding from medium or large varices, preventing spontaneous bacterial peritonitis and primary prevention of decompensation.
The Semaglutide for managing overweight and obesity technology appraisal has been updated. The update includes an additional requirement that this treatment is available in accordance with a commercial arrangement that discounts the acquisition cost for the NHS.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.